Published ahead of print on February 11, 2005, doi:10.1164/rccm.200409-1242OC
Am. J. Respir. Crit. Care Med., Volume 171, Number 10, May 2005, 1077-1082
A more recent version of this article appeared on May 15, 2005
Submitted on September 24, 2004
Accepted on January 21, 2005
Clinical Use of Non-Invasive Measurements of Airway Inflammation in Steriod Reduction in Children
Angela Zacharasiewicz1*, Nicola Wilson2, Christiane Lex3, Edward M Erin4, Albert M Li2, Trevor Hansel4, Mohammed Khan5, and Andrew Bush2
1 Department of Respiratory Pediatrics, Royal Brompton Hospital, London, United Kingdom; Department of Pediatric and Adolescent Medicine, Pulmonary and Infectious Diseases, Wilhelminenspital, Vienna, Austria,
2 Department of Respiratory Pediatrics, Royal Brompton Hospital, London, United Kingdom,
3 Department of Respiratory Pediatrics, Royal Brompton Hospital, London, United Kingdom; Department of Paediatric Cardiology and Pulmonology, Heinrich Heine University, Duesseldorf, Germany,
4 Department of Thoracic Medicine, Imperial College, Clinical Studies Unit, National Heart and Lung Institute (NHLI), London, United Kingdom,
5 Department of Health Services Research, Clinical Trials and Evaluation Unit, Royal Brompton Hospital, London, United Kingdom
* To whom correspondence should be addressed. E-mail: angela.zacharasiewicz{at}wienkav.at.
The use of non-invasive methods of monitoring airway inflammation such as exhaled nitric oxide (eNO) and induced sputum has been shown to improve asthma monitoring and optimize treatment in adult asthmatics. There is a lack of comparable data in children. 40 stable asthmatic children eligible for inhaled steroid reduction were reviewed every 8 weeks, and their inhaled steroid dose halved if clinically indicated. ENO, sputum induction (IS) combined with bronchial hyperreactivity testing (BHR) and exhaled breath condensate collection (EBC) was performed at each visit, in order to predict success or failure of reduction of inhaled steroids. 30/40 (75%) children tolerated at least one dose reduction, 12/40 (30%) were successfully weaned off and in total 15/40 (38%) children experienced loss of asthma control. Treatment reduction was successful in all children who had no eosinophils in induced sputum prior to attempted reduction. Using multiple logistic regression, increased eNO (OR 6.3, CI 3.75-10.58) and sputum eosinophils % (OR 1.38, CI 1.06-1.81) were significant predictors for failed reduction. These findings suggest that monitoring airway inflammation may be useful in optimizing treatment in children with asthma.
Key words: sputum eosinophil counts, exhaled nitric oxide, asthma, children
This article has been cited by other articles:

|
 |

|
 |
 
H. K. Reddel, D. R. Taylor, E. D. Bateman, L.-P. Boulet, H. A. Boushey, W. W. Busse, T. B. Casale, P. Chanez, P. L. Enright, P. G. Gibson, et al.
An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations: Standardizing Endpoints for Clinical Asthma Trials and Clinical Practice
Am. J. Respir. Crit. Care Med.,
July 1, 2009;
180(1):
59 - 99.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P-R. Burgel, J. de Blic, P. Chanez, C. Delacourt, P. Devillier, A. Didier, J-C. Dubus, I. Frachon, G. Garcia, M. Humbert, et al.
Update on the roles of distal airways in asthma
Eur. Respir. Rev.,
June 1, 2009;
18(112):
80 - 95.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J Henderson, R Granell, and J Sterne
The search for new asthma phenotypes
Arch. Dis. Child.,
May 1, 2009;
94(5):
333 - 336.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Taylor
Exhaled Nitric Oxide: Still Alive, Not Laid to Rest
Am. J. Respir. Crit. Care Med.,
January 15, 2009;
179(2):
88 - 89.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. de Jongste, S. Carraro, W. C. Hop, the CHARISM Study Group, and E. Baraldi
Daily Telemonitoring of Exhaled Nitric Oxide and Symptoms in the Treatment of Childhood Asthma
Am. J. Respir. Crit. Care Med.,
January 15, 2009;
179(2):
93 - 97.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D R Taylor and I D Pavord
Biomarkers in the assessment and management of airways diseases
Postgrad. Med. J.,
December 1, 2008;
84(998):
628 - 634.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. G. Lim and C. Mottram
The Use of Fraction of Exhaled Nitric Oxide in Pulmonary Practice
Chest,
May 1, 2008;
133(5):
1232 - 1242.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. E. Carpagnano, M. P. Foschino-Barbaro, A. Spanevello, O. Resta, F. Carpagnano, G. Mule, R. Pinto, S. Tommasi, and A. Paradiso
3p Microsatellite Signature in Exhaled Breath Condensate and Tumor Tissue of Patients with Lung Cancer
Am. J. Respir. Crit. Care Med.,
February 1, 2008;
177(3):
337 - 341.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bodini, D. Peroni, A. Loiacono, S. Costella, R. Pigozzi, E. Baraldi, A. L. Boner, and G. L. Piacentini
Exhaled Nitric Oxide Daily Evaluation Is Effective in Monitoring Exposure to Relevant Allergens in Asthmatic Children
Chest,
November 1, 2007;
132(5):
1520 - 1525.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. Shaw, M. A. Berry, M. Thomas, R. H. Green, C. E. Brightling, A. J. Wardlaw, and I. D. Pavord
The Use of Exhaled Nitric Oxide to Guide Asthma Management: A Randomized Controlled Trial
Am. J. Respir. Crit. Care Med.,
August 1, 2007;
176(3):
231 - 237.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Lex, F. Ferreira, A. Zacharasiewicz, A. G. Nicholson, P. L. Haslam, N. M. Wilson, T. T. Hansel, D. N. R. Payne, and A. Bush
Airway Eosinophilia in Children with Severe Asthma: Predictive Values of Noninvasive Tests
Am. J. Respir. Crit. Care Med.,
December 15, 2006;
174(12):
1286 - 1291.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Latzin, C. E. Kuehni, D. N. Baldwin, H. L. Roiha, C. Casaulta, and U. Frey
Elevated Exhaled Nitric Oxide in Newborns of Atopic Mothers Precedes Respiratory Symptoms
Am. J. Respir. Crit. Care Med.,
December 15, 2006;
174(12):
1292 - 1298.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D R Taylor, M W Pijnenburg, A D Smith, and J C D Jongste
Exhaled nitric oxide measurements: clinical application and interpretation
Thorax,
September 1, 2006;
61(9):
817 - 827.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Paraskakis, C. Brindicci, L. Fleming, R. Krol, S. A. Kharitonov, N. M. Wilson, P. J. Barnes, and A. Bush
Measurement of Bronchial and Alveolar Nitric Oxide Production in Normal Children and Children with Asthma
Am. J. Respir. Crit. Care Med.,
August 1, 2006;
174(3):
260 - 267.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. T. Perry
Clinical Use of Noninvasive Measurements of Airway Inflammation in Steroid Reduction in Children
Pediatrics,
August 1, 2006;
118(Supplement_1):
S31 - S32.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J L Heraghty and A J Henderson
Highlights in asthma 2005.
Arch. Dis. Child.,
May 1, 2006;
91(5):
422 - 425.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E. Wenzel and R. Covar
Update in asthma 2005.
Am. J. Respir. Crit. Care Med.,
April 1, 2006;
173(7):
698 - 706.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. W. Pijnenburg, E. M. Bakker, W. C. Hop, and J. C. De Jongste
Titrating Steroids on Exhaled Nitric Oxide in Children with Asthma: A Randomized Controlled Trial
Am. J. Respir. Crit. Care Med.,
October 1, 2005;
172(7):
831 - 836.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. de Jongste
Yes to NO: the first studies on exhaled nitric oxide-driven asthma treatment
Eur. Respir. J.,
September 1, 2005;
26(3):
379 - 381.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Horvath, J. Hunt, P. J. Barnes, and On behalf of the ATS/ERS Task Force on Exhaled Bre
Exhaled breath condensate: methodological recommendations and unresolved questions
Eur. Respir. J.,
September 1, 2005;
26(3):
523 - 548.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Gaston
Inhaled Corticosteroid Dose Reduction in Childhood Asthma: Is Nitrosopnea Informative?
Am. J. Respir. Crit. Care Med.,
May 15, 2005;
171(10):
1065 - 1066.
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 American Thoracic Society
|
|
|